[ad_1]
Biosimilars: A High‑worth Opportunity
Alternatives to biologic medicines, often called biosimilars, supply the identical security and effectiveness as the unique medicine, and just like generic medicine, they drive market competitors.
Why this issues to your plan:
- Biosimilars introduce market competitors, driving down costs.
- They supply extra price‑efficient remedy choices for circumstances like most cancers, rheumatoid arthritis, and Crohn’s illness.
- IBX employs most well-liked drug methods and unique contracting with biosimilar producers to maximise price financial savings.
- We’re actively monitoring and figuring out alternatives to leverage biosimilars to maximise our price financial savings alternatives for our purchasers.
Site of Care: Responsible Steering
One of our strongest instruments in combatting rising specialty drug prices on the medical profit is managing the location of care via our MCES program. For many specialty medicine administered by a well being care skilled, administration in a physician’s workplace, infusion clinic, or within the dwelling by way of a nurse isn’t solely extra handy to the member, but in addition considerably reduces prices.
The MCES program has saved over $250 million since 2012. Our Utilization Management procedures and supplier contracting facilitate website of care coordination and considerably scale back the added prices related to the administration of excessive‑price medical specialty medicine.
What This Means for You
As an employer, you wish to supply advantages that meet the evolving wants of your workers with out compromising plan sustainability. IBX helps you with: